Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Neuroblastoma is characterized by a relative paucity of recurrent somatic mutations at diagnosis. However, recent studies have shown that the mutational burden increases at relapse, likely as a result of clonal evolution of mutation-carrying cells during primary treatment. To inform the development...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-12-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5172533?pdf=render |